Stock listing
NXTC Stock Price, News, Filings & Events — Nextcure, Inc.
Selected listing: NXTC · NASDAQ · USD · US
This page tracks Nextcure, Inc.'s NXTC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NXTC:NASDAQ. NXTC:NASDAQ is the stock-level entry point for investors researching Nextcure, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nextcure, Inc. is a public company traded under the ticker NXTC in the American market. The company has a market capitalization of approximately $17.25 million. Nextcure focuses on developing innovative therapies for cancer and autoimmune diseases.
- Ticker
- NXTC:NASDAQ
- Asset type
- Stock
- Market cap
- $32.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Nextcure, Inc. NXTC:NASDAQ stock context
This page tracks Nextcure, Inc.'s NXTC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NXTC:NASDAQ. NXTC:NASDAQ is the stock-level entry point for investors researching Nextcure, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nextcure, Inc. is a public company traded under the ticker NXTC in the American market. The company has a market capitalization of approximately $17.25 million. Nextcure focuses on developing innovative therapies for cancer and autoimmune diseases.
Latest news from Nextcure, Inc.
NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
August 6, 2026
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
July 14, 2026
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecol...
June 4, 2026
NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
June 1, 2026
NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
May 7, 2026
Research Nextcure, Inc.
Nextcure, Inc. investor report
Review AI stock analysis and investor report context for NXTC:NASDAQ.
Nextcure, Inc. company profile
View the public company page for Nextcure, Inc. on 6ix.
Nextcure, Inc. news
Read company news and market updates connected to Nextcure, Inc..
Nextcure, Inc. investor events
Find investor webinars, events, and replay context for Nextcure, Inc..
Alternate listings
NXTC:BOATS
US · USD
Alternate listing for Nextcure, Inc.; the primary context on this page is NXTC:NASDAQ.
2US0:FWB
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is NXTC:NASDAQ.
2US0:GETTEX
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is NXTC:NASDAQ.
A41AKJ:LS
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is NXTC:NASDAQ.
A41AKJ:LSX
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is NXTC:NASDAQ.
2US0:MUN
DE · EUR
Alternate listing for Nextcure, Inc.; the primary context on this page is NXTC:NASDAQ.